$15M Bayer Combination Aspirin Class Settlement Gains Preliminary Approval

$15M Bayer Combination Aspirin Class Settlement Gains Preliminary Approval

BROOKLYN, N.Y. - A New York federal judge on July 23 preliminarily approved a $15 million refund class settlement for consumers who purchased Bayer Aspirin with Heart Advantage and Bayer Women's Low Dose Aspirin + Calcium (In Re: Bayer Combination Aspirin Products Marketing and Sales Practices Litigation, No. 09-md-2023, E.D. N.Y.). Subscribers may view the order available within the full article.

Find full version on lexis Advance®
Access this news story on lexis.com®